Page 217 - Advances in Textile Biotechnology
P. 217

198    Advances in textile biotechnology


              non-food applications cover the areas of biological science, tissue engineer-
              ing, material science, leather and textile processing (Zhu and  Tramper,
              2008). When the Activa® TGase available from Ajinomoto is used, care
              must be taken to consider the artefacts potentially caused by the presence
              of large amounts of maltodextrins, alone or together with sodium caseinate
              or lactose, in the commercial formulation. If undesired interferences are
              expected, these additives must be removed by applying suitable purifi cation
              procedures (Lantto et al., 2005a).


              Tissue engineering

              TGase can facilitate the manufacture of tissue engineering scaffolds with
              structural and functional properties able to support healing in vivo. Scaf-
              folds derived from collagen or gelatine are most commonly used for mam-
              malian cell growth. Enzymatic crosslinking of collagen scaffolds represents
              a viable alternative to chemical or physical approaches that may negatively
              affect cell growth. Collagen scaffolds treated with tissue or microbial TGases
              displayed enhanced cell attachment, spreading and proliferation of human

              osteoblasts and human foreskin dermal fibroblasts, and also showed a
              greater resistance to cell-mediated endogenous protease degradation (Chau
              et al., 2005). Enzymatically crosslinked, composite collagen scaffolds con-
              taining hyaluronan, one of the principal extracellular matrix components
              of native intervertebral disc tissue, showed the greatest potential for devel-
              oping an injectable cell-seeded scaffold for nucleus pulposus treatment in
              degenerated intervertebral discs (Halloran et al., 2008). Garcia et al. (2008)
              recently reported the development of enzymatic crosslinked collagen-based
              scaffolds for the production of dermal precursors with enhanced wound
              healing properties. Scaffolds crosslinked with microbial TGase provided an
              optimum substrate for cell migration, preventing wound contraction, stim-
              ulating epithelialisation and neoangiogenesis without inducing signifi cant
              infl ammatory reaction.
                Gelatine, a denatured derivative of collagen, is a versatile biomaterial
              that can be easily processed into scaffolds. However, one of gelatine draw-
              backs in tissue engineering is its solubility in aqueous medium, therefore
              gelatine-containing scaffolds for medium-to-long term applications need to
              be crosslinked. Enzymatic crosslinking may be a valid alternative to tradi-
              tional strategies using potentially toxic chemical agents, such as glutaralde-
              hyde. Moreover, the ability to control scaffold degradation in response to

              cell growth rates may represent an attractive and unique benefit of the
              enzymatically modulated scaffold structure. Increased thermal, mechanical
              and proteolytic stability and reduced citotoxicity as compared with chemi-
              cally or physically crosslinked scaffolds have been reported (Barbetta et al.,
              2006).




                                © Woodhead Publishing Limited, 2010
   212   213   214   215   216   217   218   219   220   221   222